Published in Health Qual Life Outcomes on September 02, 2004
SALpingectomy for STERilization (SALSTER) (SALSTER) | NCT03860805
The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes (2004) 1.03
Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health (2011) 1.00
Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci (2010) 0.95
Short-term exercise approaches on menopausal symptoms, psychological health, and quality of life in postmenopausal women. Obstet Gynecol Int (2010) 0.90
Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence (2013) 0.88
The effect of physical activity and body mass index on menopausal symptoms in Turkish women: a cross-sectional study in primary care. BMC Womens Health (2014) 0.85
Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Res Treat (2013) 0.84
Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women. Menopause (2014) 0.84
The Relationship between Menopausal Symptoms and Heart Rate Variability in Middle Aged Women. Korean J Fam Med (2011) 0.84
Reported symptoms before and one year after hysterectomy in African American and white women. J Womens Health (Larchmt) (2011) 0.82
Menopausal symptoms and quality of life among Saudi women visiting primary care clinics in Riyadh, Saudi Arabia. Int J Womens Health (2015) 0.80
Differential Item Functioning of the Psychological Domain of the Menopause Rating Scale. Biomed Res Int (2016) 0.79
Female Sexual Function During the Menopausal Transition in a Group of Iranian Women. J Family Reprod Health (2016) 0.78
Evaluation of effect of isoflavone on thyroid economy & autoimmunity in oophorectomised women: a randomised, double-blind, placebo-controlled trial. Indian J Med Res (2011) 0.77
Do diabetes and depressed mood affect associations between obesity and quality of life in postmenopause? Results of the KORA-F3 Augsburg population study. Health Qual Life Outcomes (2011) 0.77
The influence of selected socio-demographic variables on symptoms occurring during the menopause. Prz Menopauzalny (2015) 0.77
Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy. Support Care Cancer (2013) 0.77
Psychometric evaluation of the Midlife Women's Symptom Index in multiethnic groups. West J Nurs Res (2010) 0.76
Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat (2016) 0.76
Study Protocol: effects of acupuncture on hot flushes in perimenopausal and postmenopausal women - a multicenter randomized clinical trial. Trials (2008) 0.75
Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial. Int J Womens Health (2016) 0.75
How to measure "short-term hormonal effects"? Obstet Gynecol Int (2009) 0.75
The Effects of GnRHa plus Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial. J Pediatr Adolesc Gynecol (2016) 0.75
Quality of life and hormone use: new validation results of MRS scale. Health Qual Life Outcomes (2006) 0.75
Reducing depression during the menopausal transition: study protocol for a randomised controlled trial. Trials (2014) 0.75
Comparison of biopsychosocial functioning of women of different nationalities in the perimenopausal period. Prz Menopauzalny (2014) 0.75
Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial. Gynecol Endocrinol (2016) 0.75
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey. J Assist Reprod Genet (2015) 0.75
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91
International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes (2003) 1.70
The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric (2000) 1.62
[The Menopause Rating Scale (MRS II): methodological standardization in the German population]. Zentralbl Gynakol (2000) 1.46
[Evaluation of climacteric symptoms (Menopause Rating Scale)]. Zentralbl Gynakol (1994) 1.35
[Reliability of the Menopause Rating Scale (MRS): Investigation in the German population]. Zentralbl Gynakol (2002) 1.32
Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen. Maturitas (2000) 1.29
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception (2007) 2.44
International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes (2003) 1.70
The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes (2003) 1.39
IMS updated recommendations on postmenopausal hormone therapy. Climacteric (2007) 1.20
The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes (2003) 1.20
The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol (2004) 1.09
The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes (2004) 1.03
Introduction of Chlamydia trachomatis screening for young women in Germany. J Dtsch Dermatol Ges (2008) 1.00
Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents. J Womens Health (Larchmt) (2008) 0.90
Scale for Quality of Sexual Function (QSF) as an outcome measure for both genders? J Sex Med (2005) 0.89
Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet (2002) 0.89
Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Womens Health (2006) 0.89
Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health. Eur J Obstet Gynecol Reprod Biol (2003) 0.86
The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol (2006) 0.85
Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel. J Fam Plann Reprod Health Care (2011) 0.84
Clinical management of breast cancer in males: a report of four cases. Eur J Obstet Gynecol Reprod Biol (2002) 0.83
Expectations toward a novel male fertility control method and potential user types: results of a multinational survey. J Androl (2005) 0.83
Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer (2007) 0.82
A household panel as a tool for cost-effective health-related population surveys: validity of the "Healthcare Access Panel". Ger Med Sci (2004) 0.82
Analgesics use and ESRD in younger age: a case-control study. BMC Nephrol (2007) 0.81
Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study. Thromb J (2005) 0.80
Experiences with the French Aging Males' Symptoms (AMS) scale. Aging Male (2006) 0.80
European active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903]. BMC Womens Health (2006) 0.75
Participation in cervical cancer screening in Germany. Prev Med (2010) 0.75
The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric (2007) 0.75
"Controversial issues in climacteric medicine" series 3rd Pisa workshop "HRT in climacteric and aging brain". Pisa, Italy, 15-18 March 2003. Maturitas (2003) 0.75